Blood Transfusions Archives

Could These Drugs Become Blockbusters in the Next 4 Years?

Antibody-Drug Conjugates (ADCs), Blood Transfusions, Breast Cancer, Business, FDA, Migraine, Multiple Sclerosis, New Drug Applications, PCSK9 inhibitors, Potential Blockbusters, R&D, RNA, TROP-2, Type 2 Diabetes

Clarivate Analytics pegged 11 drugs set to enter the market during 2020 as potential blockbusters by 2024

February 18, 2020/by BioSpace

FDA Approves Genentech’s Rituxan (rituximab) in Children With Two Rare Blood Vessel Disorders

Approvals, Blood Transfusions, FDA, Granulomatosis with Microscopic Polyangiitis (MPA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Pediatrics, Rare Diseases, Vasculitis

The U.S. Food and Drug Administration approved Roche/Genentech’s Rituxan (rituximab), in combination with glucocorticoids, for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis in pediatric patients 2 years of age and older.

September 27, 2019/by Business Wire